drugset / Trial / NCT01992159
Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if treatment with romosozumab increases bone mineral density in Japanese women with postmenopausal osteoporosis.
Timeline
- Start
- 2012-10-12
- Primary completion
- 2014-10-09
- Completion
- 2015-06-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Romosozumab | Monoclonal antibody | 70 mg | Subcutaneous |
| Subject | Romosozumab | Monoclonal antibody | 140 mg | Subcutaneous |
| Subject | Romosozumab | Monoclonal antibody | 210 mg | Subcutaneous |